cdmo.directory
← Compare landing

Porton vs Sai Life Sciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/portonpharma/sailife

CategoryPortonSai Life Sciences
Listed sitecdmocdmo
SummaryPorton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.Integrated CRDMO offering discovery, development, and manufacturing services for small molecule NCE programs across 280+ global pharma and biotech clients.
Services
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Bioconjugation Services
  • Flow Chemistry & Continuous Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • CMC Analytical Development
  • Process Development
  • Stability Testing & Storage
  • Technology Transfer
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Flow Chemistry & Continuous Manufacturing
  • CMC Regulatory Submission Support
  • Solid-State Chemistry & Polymorph Screening
  • Formulation Development
  • Quality Control Testing
Modalities
  • Small Molecule
  • Peptide
  • Oligonucleotide
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Other)
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
IndicationsData not yet provided.Data not yet provided.
Locations
  • J-STAR South Plainfield R&D Site, South Plainfield, New Jersey, United States
  • J-STAR Cranbury R&D and Manufacturing Site, Cranbury, New Jersey, United States
  • Shanghai Minhang R&D Site, Shanghai, Shanghai, China
  • Shanghai Fengxian Manufacturing Site, Shanghai, Shanghai, China
  • Shanghai Pudong R&D and Manufacturing Site, Shanghai, Shanghai, China
  • Chongqing Liangjiang R&D Site, Chongqing, Chongqing, China
  • Chongqing Liangjiang Manufacturing Site, Chongqing, Chongqing, China
  • Chongqing Changshou Manufacturing Site, Chongqing, Chongqing, China
  • Jiangxi Yichun Manufacturing Site, Yichun, Jiangxi, China
  • Hubei Xiaogan Manufacturing Site, Xiaogan, Hubei, China
  • Headquarters, India, India
  • UK Office, UK, United Kingdom
  • USA Office, USA, United States
  • Boston Laboratory, Boston, Massachusetts, USA
  • Headquarters, Hyderabad, Telangana, India
  • Bidar Campus (Unit IV & VI), Bidar, Karnataka, India
  • Boston, Boston, Massachusetts, USA
  • UK Facility, United Kingdom
  • UK Operations, United Kingdom
  • Bidar Campus (API Manufacturing), Bidar, Karnataka, India
  • Integrated R&D Campus, Hyderabad, Telangana, India
  • Boston Area Site, Boston, Massachusetts, USA
CertificationsData not yet provided.
  • USFDA · Identifier: 21 CFR Part 210 and 211
  • EU · Identifier: EU cGMP guidelines
  • TGA · Identifier: TGA guidelines
  • India · Identifier: Schedule M (Indian cGMP standards)
  • My Green Lab (MGL) · Identifier: Green Lab Certification (98%+ compliance score)
  • BSE · Identifier: 544306
  • NSE · Identifier: SAILIFE
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.